ANTIVIRAL AGENTS FOR THE TREATMENT OF INFECTIONS BY CORONAVIRUSES

ANTIVIRAL AGENTS FOR THE TREATMENT OF INFECTIONS BY CORONAVIRUSES

The invention provides a CFTR modulator compound selected from the group consisting of 3-[6-[[1-(2,2-difluoro-1,3-benzodioxol -5-yl) cyclopropanecarbonyl] amino] -3-methylpyridin -2-yl]benzoic acid and/or N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide and pharmaceutically acce...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SOLA GURPEGUI, María Isabel, ENJUANES SÁNCHEZ, Luis, HONRUBIA BELENGUER, José Manuel, ZÚÑIGA LUCAS, Sonia
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention provides a CFTR modulator compound selected from the group consisting of 3-[6-[[1-(2,2-difluoro-1,3-benzodioxol -5-yl) cyclopropanecarbonyl] amino] -3-methylpyridin -2-yl]benzoic acid and/or N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide and pharmaceutically acceptable salts or deuterated derivatives thereof for use in the treatment of an infection produced by a Betacoronavirus in a subject and compositions comprising said compounds.